<DOC>
	<DOCNO>NCT02267902</DOCNO>
	<brief_summary>The objective study evaluate absolute bioavailability , absorption excretion DA-1229 , IMP clinical assessment treatment T2DM . The oral IV PK DA-1229 also evaluate . The metabolism DA-1229 may also evaluate .</brief_summary>
	<brief_title>Microtracer Study Establish Absolute Bioavailability Absorption , Metabolism , Excretion DA-1229</brief_title>
	<detailed_description />
	<criteria>Healthy male Age 18 55 BMI 18.0 30.0 kg/„é° History drug alcohol abuse past 2years Regular alcohol consumption nin male &gt; 21 unit per week Current smoker smoke within last 12months Radiation Exposure Positive drug abuse test result Positive HBsAg , HCV Ab , HIV result Serious adverse reaction hypersensitivity drug formulation excipients Clinically significant allergy Donation loss blood within previous 3 month Taking prescribed OTC drug herbal remedy 14days IMP administration</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Volunteers</keyword>
</DOC>